KFDA Prohibits Current Use of Company Initials from Required Identification Label

Published: 2004-12-17 06:57:00

Updated: 2004-12-17 06:57:00

The Korea Food and Drug Administration (KFDA) recently set a ruling on the pharmaceutical manufacturers’ debate over the company name identification label to be specified on the oral medications of solid type, such as capsules and tablets.

The original drug identification label requirement, wh...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK